EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RUNX1 Is an Independent Prognostic Marker Involved in Immune Infiltration and Therapeutic Responses in Clear Cell Renal Cell Carcinoma Patients Through Cluster Regulation With RUNX2

Jingang Jian, Jun Zhang, Hongbo Xu, He Wang iD, Jianquan Hou

Immunity, Inflammation and Disease · 2025-08 · 13 (8)

DOI: 10.1002/iid3.70242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 14.08.2025. Verfasst von Jingang Jian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Fourth Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Core Binding Factor Alpha 2 Subunit, Biomarkers, Tumor. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by the Key Research and Development Program of Jiangsu Province (Grant no. BE2020655), the Suzhou Applied Basic Research (Healthcare) T….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immunomodulation is an important factor in clear cell renal cell carcinoma (ccRCC) carcinogenesis and the treatment outcome of ccRCC patients. Understanding of the roles of the immune‐related Runt‐related transcription factor (RUNX) family genes in ccRCC remains controversial, and the mechanisms underlying their cluster regulation and immunomodulatory effects still need to be further investigated.

Methods

The “limma” package was used for differential gene expression analysis of TCGA and GEO data, and the “clusterProfiler” package was used for GO and KEGG enrichment analyses of coexpressed and differentially expressed genes. The “MCPCounter” algorithm and “CIBERSORT” algorithm were used to explore the correlation between gene expression and immune cell infiltration, and prognostic models were constructed using the “rms” package.

Results

RUNX1/2/3 showed elevated expression in ccRCC, with high expression of RUNX1/2 correlating with advanced clinicopathological characteristics and poor prognosis. Functional enrichment analysis and immune infiltration scores indicated that RUNX1/2 are extensively involved in the formation of the tumor immunosuppressive microenvironment. Analyses of immune checkpoint data and immunotherapy responses suggest that RUNX1 may inhibit immunotherapy effects. Multi‐Cox regression models confirmed that RUNX1 can be used as an independent prognostic indicator. In addition, an efficient clinical prognostic model can be constructed based on RUNX1 combined with several clinicopathological characteristics (AUC = 0.872).

Conclusion

Our study reveals the potential value of RUNX1/2 in ccRCC development, prognosis, and immune microenvironment regulation. RUNX1 is a promising biomarker for the tumor immunotherapy response. Furthermore, the RUNX1‐based prognostic model has the prospect of serving as a better predictive model for clinical ccRCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsCore Binding Factor Alpha 2 SubunitBiomarkers, TumorCore Binding Factor Alpha 1 SubunitHumansPrognosisGene Expression Regulation, NeoplasticTumor MicroenvironmentFemaleMaleMiddle AgedImmunotherapyGene Expression Profiling

Stichwörter der Autor:innen

RUNX1RUNX2ccRCCcluster regulationimmune infiltrationprognosistherapeutic response

Substanzen

Core Binding Factor Alpha 2 SubunitBiomarkers, TumorRUNX1 protein, humanRUNX2 protein, humanCore Binding Factor Alpha 1 Subunit

Autor:innen und Institutionen

  • Department of Urology, The Fourth Affiliated Hospital of Soochow University, Suzhou, China.
  • Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou, China.

ORCID-Profile: He Wang

Förderung

  • This work was supported by the Key Research and Development Program of Jiangsu Province (Grant no. BE2020655), the Suzhou Applied Basic Research (Healthcare) T…

Zitieren

APA

Jian, J., Zhang, J., Xu, H., Wang, H., & Hou, J. (2025). RUNX1 Is an Independent Prognostic Marker Involved in Immune Infiltration and Therapeutic Responses in Clear Cell Renal Cell Carcinoma Patients Through Cluster Regulation With RUNX2. Immunity, Inflammation and Disease, 13(8). https://doi.org/10.1002/iid3.70242

Vancouver

Jian J, Zhang J, Xu H, Wang H, Hou J. RUNX1 Is an Independent Prognostic Marker Involved in Immune Infiltration and Therapeutic Responses in Clear Cell Renal Cell Carcinoma Patients Through Cluster Regulation With RUNX2. Immunity, Inflammation and Disease. 2025;13(8). doi:10.1002/iid3.70242

BibTeX
@article{Jian2025,
  author = {Jian, Jingang and Zhang, Jun and Xu, Hongbo and Wang, He and Hou, Jianquan},
  title = {RUNX1 Is an Independent Prognostic Marker Involved in Immune Infiltration and Therapeutic Responses in Clear Cell Renal Cell Carcinoma Patients Through Cluster Regulation With RUNX2},
  journal = {Immunity, Inflammation and Disease},
  year = {2025},
  volume = {13},
  number = {8},
  doi = {10.1002/iid3.70242}
}
Kostenlos starten →